Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2023-06-16 | 2023-06-27 | 195136 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2021-06-03 | 2021-07-09 | 140366 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2022-08-18 | 2023-01-26 | 167234 |
| RATIO-TOPISALIC | 0.5MG 20MG | LOTION | Resolved | 2019-11-14 | 2020-03-26 | 98744 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2022-03-24 | 2022-04-09 | 157250 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2024-01-18 | 2024-06-29 | 216463 |
| RATIO-TOPISALIC | 0.5MG 20MG | LOTION | Resolved | 2017-08-01 | 2017-10-10 | 17827 |
| RATIO-TOPISALIC | 0.5MG 20MG | LOTION | Resolved | 2017-08-01 | 2017-10-10 | 17822 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2023-02-09 | 2023-06-27 | 184192 |
| RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Resolved | 2021-08-27 | 2021-09-30 | 144718 |
| RATIO-TOPISALIC | 0.5MG 20MG | LOTION | Resolved | 2020-07-23 | 2020-10-15 | 120911 |
| RATIO-TOPISONE | 0.05% | LOTION | Resolved | 2017-04-25 | 2018-01-03 | 8055 |
| RATIO-TOPISONE | 0.05% | LOTION | Resolved | 2017-08-01 | 2017-10-17 | 17832 |
| REMIFENTANIL FOR INJECTION | 2MG | POWDER FOR SOLUTION | Actual shortage | 2020-01-24 | 2020-01-24 | 104316 |
| REMIFENTANIL FOR INJECTION | 1MG | POWDER FOR SOLUTION | Actual shortage | 2020-01-24 | 2020-01-24 | 104313 |
| REVIA | 50MG | TABLET | Resolved | 2024-01-11 | 2024-02-13 | 215710 |
| REVIA | 50MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190707 |
| REVIA | 50MG | TABLET | Resolved | 2025-05-15 | 2025-07-03 | 257513 |
| SEASONALE | 0.15MG 0.03MG | TABLET | Resolved | 2020-10-08 | 2021-02-25 | 126038 |
| SEASONALE | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176815 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NAPROXEN SODIUM | 275MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258522 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
| TEVA-OLMESARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258409 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258412 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258405 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258400 |
| TEVA-OLMESARTAN / HCTZ | 25MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258396 |
| TEVA-ONDANSETRON | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258774 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258729 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
| TEVA-PAROXETINE | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258433 |
| TEVA-PAROXETINE | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258430 |